Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens, Nikolaos P. Polyzos, Dominic Stoop, Michel Camus, Paul Devroey Reproductive BioMedicine Online Volume 24, Issue 3, Pages 272-280 (March 2012) DOI: 10.1016/j.rbmo.2011.11.012 Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Schematic overview of both treatment groups. GnRH=gonadotrophin-releasing hormone; HCG=human chorionic gonadotrophin. Reproductive BioMedicine Online 2012 24, 272-280DOI: (10.1016/j.rbmo.2011.11.012) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Study flow chart diagram. OR=oocyte retrival. Reproductive BioMedicine Online 2012 24, 272-280DOI: (10.1016/j.rbmo.2011.11.012) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 3 Oocyte retrieval by day in both treatment groups. The distribution of oocyte retrieval by day for patients randomized to control or pretreatment group was analysed by the Fisher’s exact test (P=0.039). Reproductive BioMedicine Online 2012 24, 272-280DOI: (10.1016/j.rbmo.2011.11.012) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions